Author:
Bunc Matjaž,Mrak Miha,Rakovec Peter
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Wiebe J, Nef HM, Hamm CW. Current status of bioresorbable scaffolds in the treatment of coronary artery disease. J Am Coll Cardiol. 2014;64:2541–51.
2. Serruys PW, Ormiston JA, Onuma Y, et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897–910.
3. Latib A, Costopoulos C, Naganuma T, et al. Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice. Minerva Cardioangiol. 2013;61:255–62.
4. Serruys PW, Garcia-Garcia HM, Onuma Y. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? Eur Heart J. 2012;33:16–25.
5. Windecker S, Kolh P, Alfonso F, et al. ESC/EACTS guidelines on myocardial revascularization. Eur Heart J. 2014;35:2541–619.